{"id":25637,"date":"2016-11-09T17:30:21","date_gmt":"2016-11-09T16:30:21","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=25637"},"modified":"2016-11-09T17:30:21","modified_gmt":"2016-11-09T16:30:21","slug":"curs-sobre-anticoagulants-orals-daccio-directa-en-fibril%c2%b7lacio-auricular-no-valvular","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2016\/11\/09\/curs-sobre-anticoagulants-orals-daccio-directa-en-fibril%c2%b7lacio-auricular-no-valvular\/","title":{"rendered":"Curs sobre anticoagulants orals d\u2019acci\u00f3 directa en fibril\u00b7laci\u00f3 auricular no valvular"},"content":{"rendered":"<p>En els \u00faltims anys s\u2019han desenvolupat <b>medicaments anticoagulants nous (NACO)<\/b> que han demostrat un benefici-risc favorable en diverses condicions cl\u00edniques en qu\u00e8 est\u00e0 indicada aquesta medicaci\u00f3. La utilitzaci\u00f3 dels anticoagulants orals d\u2019acci\u00f3 directa (ACODS) s\u2019ha associat a beneficis i inconvenients comparats amb l\u2019\u00fas dels antagonistes de la vitamina K (AVK) que han estat mat\u00e8ria de discussi\u00f3 en les avaluacions de les ag\u00e8ncies reguladores. <b>En els pr\u00f2xims anys, la publicaci\u00f3 dels resultats dels assaigs cl\u00ednics en noves condicions d\u2019\u00fas i l\u2019experi\u00e8ncia post-comercialitzaci\u00f3 adquirida contribuiran a delimitar de forma m\u00e9s s\u00f2lida el posicionament d\u2019aquests f\u00e0rmacs<\/b>. Actualment, hi ha <b>necessitat d\u2019establir unes recomanacions d\u2019\u00fas per als ACODs<\/b>\u00a0i identificar els pacients en qu\u00e8 els avantatges del nou tractament s\u00f3n superiors als inconvenients.<\/p>\n<p style=\"text-align: center;\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/11\/curs-anticoagulants-orals-4.jpg\"><img fetchpriority=\"high\" decoding=\"async\" class=\" wp-image-25642 aligncenter\" alt=\"curs-anticoagulants-orals (4)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/11\/curs-anticoagulants-orals-4.jpg\" width=\"610\" height=\"302\" \/><\/a><\/p>\n<p>El <strong>curs sobre anticoagulants orals d\u2019acci\u00f3 directa en fibril\u00b7laci\u00f3 auricular no valvular<\/strong>, que va acollir el COFB el 19 d\u2019octubre, va aplegar<strong> farmac\u00e8utics comunitaris, d\u2019hospitals, de centres d\u2019atenci\u00f3 prim\u00e0ria i de l\u2019administraci\u00f3 sanit\u00e0ria<\/strong>. Els assistents van poder:<\/p>\n<ul>\n<li><strong>Actualitzar els coneixements en la ter\u00e0pia amb ACODs<\/strong>\u00a0en les diferents situacions cl\u00edniques que ho requereixen en la prevenci\u00f3 de l&#8217;ictus i de l&#8217;emb\u00f2lia sist\u00e8mica en fibril\u00b7laci\u00f3 auricular no valvular.<\/li>\n<li><strong>Con\u00e8ixer la ruta de la fibril\u00b7laci\u00f3 auricular (FA)<\/strong> del Pla director de l\u2019ictus a Catalunya.<\/li>\n<li><strong>Interrelacionar la seguretat farmacol\u00f2gica, l\u2019adher\u00e8ncia i l\u2019efic\u00e0cia terap\u00e8utica dels ACODs<\/strong>.<\/li>\n<li><strong>Presentar el q\u00fcestionari PRO (Patient-Reported Outcomes)<\/strong> que recull la qualitat de vida i resultat de salut percebut pels pacients.<\/li>\n<\/ul>\n<p style=\"text-align: center;\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/11\/curs-anticoagulants-orals-1.jpg\"><img decoding=\"async\" class=\" wp-image-25639 aligncenter\" alt=\"curs-anticoagulants-orals (1)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/11\/curs-anticoagulants-orals-1.jpg\" width=\"611\" height=\"299\" \/><\/a><\/p>\n<p>Aquest curs es va plantejar com una <b>reflexi\u00f3 conjunta de diferents especialistes<\/b> amb punts de vista diversos sobre el paper d\u2019aquests tractaments en terap\u00e8utica tenint en compte aspectes de seguretat farmacol\u00f2gica, adher\u00e8ncia al tractament, d\u2019efectivitat i de cost-efectivitat. Es va poder assistir presencialment i online en directe a temps real via connexi\u00f3 Webinar.<\/p>\n<figure id=\"attachment_25641\" aria-describedby=\"caption-attachment-25641\" style=\"width: 255px\" class=\"wp-caption alignleft\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/11\/curs-anticoagulants-orals-3.jpg\"><img decoding=\"async\" class=\" wp-image-25641  \" alt=\"curs-anticoagulants-orals (3)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/11\/curs-anticoagulants-orals-3.jpg\" width=\"255\" height=\"170\" \/><\/a><figcaption id=\"caption-attachment-25641\" class=\"wp-caption-text\">D&#8217;esquerra a dreta: Bagaria (COFB), Pinyol (INNOVA &#8211; strategic consulting), Abilleira i Gallofr\u00e9 (Departament Salut), Jacob (Hospital Bellvitge)<\/figcaption><\/figure>\n<p>El quadre docent va estar format per <b>S\u00f2nia Abilleira<\/b>, neur\u00f2loga, i \u00a0<b>Miquel Gallofr\u00e9<\/b>, director, ambd\u00f3s del Pla director de la malaltia vascular cerebral del Departament de Salut; <b>Javier Jacob<\/b>, metge adjunt d\u2019urg\u00e8ncies, responsable de Formaci\u00f3 i Investigaci\u00f3 del Servei d\u2019Urg\u00e8ncies de l\u2019Hospital Universitari de Bellvitge; i <b>Carme Pinyol<\/b>, fundadora i directora de INNOVA-strategic consulting, presidenta del ISPOR Regional Spain Chapter, i directora de la \u201cRevista Espa\u00f1ola de Econom\u00eda de la Salud\u201d (\u20acDS).<\/p>\n<p>la formaci\u00f3 va estar coordinada per tres responsables del COFB: <b>Cristina Rodr\u00edguez<\/b>, cap del Departament de Formaci\u00f3 i Desenvolupament Professional, <b>Guillermo Bagaria<\/b>, vocal de la Junta de Govern, i <b>Roser Vall\u00e8s<\/b>, vocal d\u2019Atenci\u00f3 Prim\u00e0ria; i per <b>Julio Mart\u00ednez<\/b>, president de la Societat Catalana de Farm\u00e0cia Cl\u00ednica (SCFC), entitat coorganitzadora de la formaci\u00f3.<\/p>\n<div class=\"box shadow\">\u201cEl rep\u00e0s a les ter\u00e0pies anticoagulants directes i els estudis cost efic\u00e0cia dels mateixos van quedar perfectament emmarcats en el si de la campanya \u2018Pren-te el pols\u2019 en qu\u00e8 el farmac\u00e8utic pot tenir un paper molt important i que tot just encetem els pr\u00f2xims dies\u201d explica Bagaria.<\/div>\n<p align=\"right\"><b>Amb la col\u00b7laboraci\u00f3 de:<\/b><\/p>\n<p align=\"right\"><a href=\"https:\/\/www.daiichi-sankyo.es\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignright  wp-image-25643\" alt=\"DAIICHI-SANKYO\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/11\/DAIICHI-SANKYO.jpg\" width=\"96\" height=\"93\" \/><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>En els \u00faltims anys s\u2019han desenvolupat medicaments anticoagulants nous (NACO) que han demostrat un benefici-risc favorable en diverses condicions cl\u00edniques en qu\u00e8 est\u00e0 indicada aquesta medicaci\u00f3. La utilitzaci\u00f3 dels anticoagulants orals d\u2019acci\u00f3 directa (ACODS) s\u2019ha associat a beneficis i inconvenients comparats amb l\u2019\u00fas dels antagonistes de la vitamina K (AVK) [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":25640,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[2551,1010,938,2552,69,480,2553,70,2554,2555,286],"class_list":["post-25637","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-acods","tag-anticoagulants-orals","tag-atencio-primaria","tag-avk","tag-farmacia-comunitaria","tag-farmacia-hospitalaria","tag-fibrillacio-auricular-no-valvular","tag-formacio","tag-ictus","tag-naco","tag-societat-catalana-de-farmacia-clinica"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Curs sobre anticoagulants orals d\u2019acci\u00f3 directa en fibril\u00b7laci\u00f3 auricular no valvular<\/title>\n<meta name=\"description\" content=\"Curs sobre anticoagulants orals d\u2019acci\u00f3 directa en fibril\u00b7laci\u00f3 auricular no valvular. Curs COFB en col\u00b7laboraci\u00f3 amb Societat Catalana de Farm\u00e0cia Cl\u00ednica\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2016\/11\/09\/curs-sobre-anticoagulants-orals-daccio-directa-en-fibril\u00b7lacio-auricular-no-valvular\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Curs sobre anticoagulants orals d\u2019acci\u00f3 directa en fibril\u00b7laci\u00f3 auricular no valvular\" \/>\n<meta property=\"og:description\" content=\"Curs sobre anticoagulants orals d\u2019acci\u00f3 directa en fibril\u00b7laci\u00f3 auricular no valvular. Curs COFB en col\u00b7laboraci\u00f3 amb Societat Catalana de Farm\u00e0cia Cl\u00ednica\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2016\/11\/09\/curs-sobre-anticoagulants-orals-daccio-directa-en-fibril\u00b7lacio-auricular-no-valvular\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2016-11-09T16:30:21+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/11\/09\/curs-sobre-anticoagulants-orals-daccio-directa-en-fibril%c2%b7lacio-auricular-no-valvular\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/11\/09\/curs-sobre-anticoagulants-orals-daccio-directa-en-fibril%c2%b7lacio-auricular-no-valvular\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Curs sobre anticoagulants orals d\u2019acci\u00f3 directa en fibril\u00b7laci\u00f3 auricular no valvular\",\"datePublished\":\"2016-11-09T16:30:21+00:00\",\"dateModified\":\"2016-11-09T16:30:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/11\/09\/curs-sobre-anticoagulants-orals-daccio-directa-en-fibril%c2%b7lacio-auricular-no-valvular\/\"},\"wordCount\":573,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/11\/09\/curs-sobre-anticoagulants-orals-daccio-directa-en-fibril%c2%b7lacio-auricular-no-valvular\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"ACODS\",\"anticoagulants orals\",\"Atenci\u00f3 prim\u00e0ria\",\"AVK\",\"farm\u00e0cia comunit\u00e0ria\",\"farm\u00e0cia hospital\u00e0ria\",\"fibril\u00b7laci\u00f3 auricular no valvular\",\"Formaci\u00f3\",\"ictus\",\"NACO\",\"Societat Catalana de Farm\u00e0cia Cl\u00ednica\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2016\/11\/09\/curs-sobre-anticoagulants-orals-daccio-directa-en-fibril%c2%b7lacio-auricular-no-valvular\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/11\/09\/curs-sobre-anticoagulants-orals-daccio-directa-en-fibril%c2%b7lacio-auricular-no-valvular\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2016\/11\/09\/curs-sobre-anticoagulants-orals-daccio-directa-en-fibril%c2%b7lacio-auricular-no-valvular\/\",\"name\":\"Curs sobre anticoagulants orals d\u2019acci\u00f3 directa en fibril\u00b7laci\u00f3 auricular no valvular\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/11\/09\/curs-sobre-anticoagulants-orals-daccio-directa-en-fibril%c2%b7lacio-auricular-no-valvular\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/11\/09\/curs-sobre-anticoagulants-orals-daccio-directa-en-fibril%c2%b7lacio-auricular-no-valvular\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2016-11-09T16:30:21+00:00\",\"dateModified\":\"2016-11-09T16:30:21+00:00\",\"description\":\"Curs sobre anticoagulants orals d\u2019acci\u00f3 directa en fibril\u00b7laci\u00f3 auricular no valvular. Curs COFB en col\u00b7laboraci\u00f3 amb Societat Catalana de Farm\u00e0cia Cl\u00ednica\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/11\/09\/curs-sobre-anticoagulants-orals-daccio-directa-en-fibril%c2%b7lacio-auricular-no-valvular\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2016\/11\/09\/curs-sobre-anticoagulants-orals-daccio-directa-en-fibril%c2%b7lacio-auricular-no-valvular\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/11\/09\/curs-sobre-anticoagulants-orals-daccio-directa-en-fibril%c2%b7lacio-auricular-no-valvular\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/11\/09\/curs-sobre-anticoagulants-orals-daccio-directa-en-fibril%c2%b7lacio-auricular-no-valvular\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Curs sobre anticoagulants orals d\u2019acci\u00f3 directa en fibril\u00b7laci\u00f3 auricular no valvular\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Curs sobre anticoagulants orals d\u2019acci\u00f3 directa en fibril\u00b7laci\u00f3 auricular no valvular","description":"Curs sobre anticoagulants orals d\u2019acci\u00f3 directa en fibril\u00b7laci\u00f3 auricular no valvular. Curs COFB en col\u00b7laboraci\u00f3 amb Societat Catalana de Farm\u00e0cia Cl\u00ednica","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2016\/11\/09\/curs-sobre-anticoagulants-orals-daccio-directa-en-fibril\u00b7lacio-auricular-no-valvular\/","og_locale":"ca_ES","og_type":"article","og_title":"Curs sobre anticoagulants orals d\u2019acci\u00f3 directa en fibril\u00b7laci\u00f3 auricular no valvular","og_description":"Curs sobre anticoagulants orals d\u2019acci\u00f3 directa en fibril\u00b7laci\u00f3 auricular no valvular. Curs COFB en col\u00b7laboraci\u00f3 amb Societat Catalana de Farm\u00e0cia Cl\u00ednica","og_url":"https:\/\/novaorg.cofb.net\/2016\/11\/09\/curs-sobre-anticoagulants-orals-daccio-directa-en-fibril\u00b7lacio-auricular-no-valvular\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2016-11-09T16:30:21+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"3 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2016\/11\/09\/curs-sobre-anticoagulants-orals-daccio-directa-en-fibril%c2%b7lacio-auricular-no-valvular\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2016\/11\/09\/curs-sobre-anticoagulants-orals-daccio-directa-en-fibril%c2%b7lacio-auricular-no-valvular\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Curs sobre anticoagulants orals d\u2019acci\u00f3 directa en fibril\u00b7laci\u00f3 auricular no valvular","datePublished":"2016-11-09T16:30:21+00:00","dateModified":"2016-11-09T16:30:21+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2016\/11\/09\/curs-sobre-anticoagulants-orals-daccio-directa-en-fibril%c2%b7lacio-auricular-no-valvular\/"},"wordCount":573,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2016\/11\/09\/curs-sobre-anticoagulants-orals-daccio-directa-en-fibril%c2%b7lacio-auricular-no-valvular\/#primaryimage"},"thumbnailUrl":"","keywords":["ACODS","anticoagulants orals","Atenci\u00f3 prim\u00e0ria","AVK","farm\u00e0cia comunit\u00e0ria","farm\u00e0cia hospital\u00e0ria","fibril\u00b7laci\u00f3 auricular no valvular","Formaci\u00f3","ictus","NACO","Societat Catalana de Farm\u00e0cia Cl\u00ednica"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2016\/11\/09\/curs-sobre-anticoagulants-orals-daccio-directa-en-fibril%c2%b7lacio-auricular-no-valvular\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2016\/11\/09\/curs-sobre-anticoagulants-orals-daccio-directa-en-fibril%c2%b7lacio-auricular-no-valvular\/","url":"https:\/\/novaorg.cofb.net\/2016\/11\/09\/curs-sobre-anticoagulants-orals-daccio-directa-en-fibril%c2%b7lacio-auricular-no-valvular\/","name":"Curs sobre anticoagulants orals d\u2019acci\u00f3 directa en fibril\u00b7laci\u00f3 auricular no valvular","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2016\/11\/09\/curs-sobre-anticoagulants-orals-daccio-directa-en-fibril%c2%b7lacio-auricular-no-valvular\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2016\/11\/09\/curs-sobre-anticoagulants-orals-daccio-directa-en-fibril%c2%b7lacio-auricular-no-valvular\/#primaryimage"},"thumbnailUrl":"","datePublished":"2016-11-09T16:30:21+00:00","dateModified":"2016-11-09T16:30:21+00:00","description":"Curs sobre anticoagulants orals d\u2019acci\u00f3 directa en fibril\u00b7laci\u00f3 auricular no valvular. Curs COFB en col\u00b7laboraci\u00f3 amb Societat Catalana de Farm\u00e0cia Cl\u00ednica","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2016\/11\/09\/curs-sobre-anticoagulants-orals-daccio-directa-en-fibril%c2%b7lacio-auricular-no-valvular\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2016\/11\/09\/curs-sobre-anticoagulants-orals-daccio-directa-en-fibril%c2%b7lacio-auricular-no-valvular\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2016\/11\/09\/curs-sobre-anticoagulants-orals-daccio-directa-en-fibril%c2%b7lacio-auricular-no-valvular\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2016\/11\/09\/curs-sobre-anticoagulants-orals-daccio-directa-en-fibril%c2%b7lacio-auricular-no-valvular\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Curs sobre anticoagulants orals d\u2019acci\u00f3 directa en fibril\u00b7laci\u00f3 auricular no valvular"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"En els \u00faltims anys s\u2019han desenvolupat medicaments anticoagulants nous (NACO) que han demostrat un benefici-risc favorable en diverses condicions cl\u00edniques en qu\u00e8 est\u00e0 indicada aquesta medicaci\u00f3. La utilitzaci\u00f3 dels anticoagulants orals d\u2019acci\u00f3 directa (ACODS) s\u2019ha associat a beneficis i inconvenients comparats amb l\u2019\u00fas dels antagonistes de la vitamina K (AVK) [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/25637","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=25637"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/25637\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=25637"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=25637"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=25637"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}